Orthofix Medical
OFIX
149 hedge funds and large institutions have $597M invested in Orthofix Medical in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 50 increasing their positions, 59 reducing their positions, and 21 closing their positions.
9% more capital invested
Capital invested by funds: $546M → $597M (+$50.8M)
1.12% more ownership
Funds ownership: 89.33% → 90.45% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less funds holding
Funds holding: 162 → 149 (-13)
15% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 59
57% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 21
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$11.2M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$6.51M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
+$5.92M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$3.77M |
| 5 |
First Eagle Investment Management
New York
|
+$3.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$7M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$6.36M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$3.58M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.3M |
| 5 |
AIC
AWM Investment Company
New York
|
-$2.27M |
OFIX Hedge Fund Activity: Q2 2023 in Review
149 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q2 2023, worth a combined $597M — up 9.3% from $546M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of OFIX and 9 opened new positions — a net loss of 12 holders — while 59 trimmed existing stakes and 50 added.
The largest buyer was Armistice Capital, adding an estimated $11.2M. The largest seller was JP Morgan Chase, cutting an estimated $7M.
- 149 institutional investors held Orthofix Medical (OFIX) as of Q2 2023, down from 162 in Q1 2023.
- Funds reported $597M of Orthofix Medical stock for Q2 2023, up 9.3% quarter-over-quarter.
- 9 funds opened new Orthofix Medical positions in Q2 2023 and 21 closed out, a net change of -12 holders.
- The largest Orthofix Medical buyer in Q2 2023 was Armistice Capital, an estimated $11.2M added.
- The largest Orthofix Medical seller in Q2 2023 was JP Morgan Chase, an estimated $7M sold.
Based on aggregated 13F filings for Q2 2023.